Health Technology Committee Meeting

Speaker Bio - January 19, 2010

Dietrich A. Stephan, Ph.D.
President & CEO
Ignite Institute

Dr. Stephan is a widely recognized visionary in the field of molecular medicine and currently serves as the President and CEO of the Ignite Inova Institute. He founded the Institute in 2009 in his quest to change the medical paradigm from reactive and generalized to proactive and personalized through the implementation of molecularly informed, tactical solutions.

Dr. Stephen is a pioneer in personalized medicine and founded a number of companies, including Navigenics, Amnestix, and Aeuon, Inc. Prior to this, Dr. Stephan served as a Senior Investigator and founding Chairman of the Department of Neurogenomics at The Translational Genomics Research Institute (TGen) in Phoenix, Arizona and later moved into the role of Deputy Director of Discovery Research at TGen. During his time at TGen, Stephan and his colleagues were among the first to use the Affymetrix gene chip platform to identify genetic links for a number of neurological disorders including autism, ALS, Sudden infant death syndrome (SIDS) and Alzheimer's disease.

Dr. Stephan has held faculty appointments at Johns Hopkins University, George Washington University and the University of Arizona. He is the author of over 140 scientific publications and has been highlighted twice on the front page of the Wall Street Journal for his contributions to the field of medicine.

Dr. Stephan received a B.S. in Biology/Biochemistry from Carnegie Mellon University in 1991 and a Ph.D. in Human Molecular Genetics from the University of Pittsburgh in 1996. He completed a fellowship at the National Human Genome Research Institute in 1999.